BANDARAMHealthcare Service Provider
Bandaram Pharma Packtech Ltd — Profit & Loss Statement
₹23.53
-8.48%
Bandaram Pharma Packtech Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Tax Rate For Calcs | 0.24 | 0.20 | 0.21 | 0.00 | — |
| Normalized EBITDA | 2.92 Cr | 2.85 Cr | 1.26 Cr | -0.01 Cr | — |
| Total Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income From Continuing Operation Net Minority Interest | 0.99 Cr | 0.95 Cr | 0.26 Cr | -0.01 Cr | — |
| Reconciled Depreciation | 0.61 Cr | 0.71 Cr | 0.58 Cr | 0.00 | — |
| Reconciled Cost Of Revenue | 29.65 Cr | 27.55 Cr | 16.05 Cr | 0.00 | — |
| EBITDA | 2.92 Cr | 2.85 Cr | 1.26 Cr | -0.01 Cr | — |
| EBIT | 1.93 Cr | 2.12 Cr | 0.67 Cr | -0.01 Cr | — |
| Net Interest Income | -0.61 Cr | -0.93 Cr | -0.43 Cr | -1436.00 | — |
| Interest Expense | 0.61 Cr | 0.93 Cr | 0.35 Cr | 1436.00 | — |
| Normalized Income | 0.99 Cr | 0.95 Cr | 0.26 Cr | -0.01 Cr | — |
| Net Income From Continuing And Discontinued Operation | 0.99 Cr | 0.95 Cr | 0.26 Cr | -0.01 Cr | — |
| Total Expenses | 35.13 Cr | 31.99 Cr | 18.02 Cr | 0.01 Cr | — |
| Diluted NI Availto Com Stockholders | 0.99 Cr | 0.95 Cr | 0.26 Cr | -0.01 Cr | — |
| Net Income Common Stockholders | 0.99 Cr | 0.95 Cr | 0.26 Cr | -0.01 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 0.99 Cr | 0.95 Cr | 0.26 Cr | -0.01 Cr | — |
| Net Income Including Noncontrolling Interests | 0.99 Cr | 0.95 Cr | 0.26 Cr | -0.01 Cr | — |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Continuous Operations | 0.99 Cr | 0.95 Cr | 0.26 Cr | -0.01 Cr | — |
| Tax Provision | 0.32 Cr | 0.24 Cr | 0.07 Cr | 0.00 | — |
| Pretax Income | 1.32 Cr | 1.19 Cr | 0.33 Cr | -0.01 Cr | — |
| Other Non Operating Income Expenses | 0.09 Cr | 0.03 Cr | 0.04 Cr | — | — |
| Special Income Charges | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Non Operating Interest Income Expense | -0.61 Cr | -0.93 Cr | -0.43 Cr | -1436.00 | — |
| Interest Expense Non Operating | 0.61 Cr | 0.93 Cr | 0.35 Cr | 1436.00 | — |
| Operating Income | 1.83 Cr | 2.09 Cr | 0.71 Cr | -0.01 Cr | — |
| Operating Expense | 5.48 Cr | 4.44 Cr | 1.97 Cr | 0.01 Cr | — |
| Other Operating Expenses | 1.53 Cr | 1.38 Cr | 0.67 Cr | 0.01 Cr | — |
| Depreciation And Amortization In Income Statement | 0.99 Cr | 0.73 Cr | 0.59 Cr | 0.00 | — |
| Depreciation Income Statement | 0.99 Cr | 0.73 Cr | 0.59 Cr | 0.00 | — |
| Gross Profit | 7.31 Cr | 6.53 Cr | 2.68 Cr | 0.00 | — |
| Cost Of Revenue | 29.65 Cr | 27.55 Cr | 16.05 Cr | 0.00 | — |
| Total Revenue | 36.96 Cr | 34.08 Cr | 18.73 Cr | 0.00 | — |
| Operating Revenue | 36.96 Cr | 34.08 Cr | 18.73 Cr | 0.00 | — |
| Interest Income | — | 15000.00 | 34000.00 | 0.00 | 0.00 |
| Rent Expense Supplemental | — | 0.70 Cr | 0.12 Cr | 0.00 | — |
| Diluted Average Shares | — | 1.20 Cr | 0.30 Cr | 0.02 Cr | — |
| Basic Average Shares | — | 1.20 Cr | 0.30 Cr | 0.02 Cr | — |
| Diluted EPS | — | 0.79 | 0.47 | -0.50 | — |
| Basic EPS | — | 0.79 | 0.47 | -0.50 | — |
| Minority Interests | — | -0.43 Cr | -0.12 Cr | 0.00 | — |
| Total Other Finance Cost | — | 0.08 Cr | 0.09 Cr | — | — |
| Interest Income Non Operating | — | 15000.00 | 34000.00 | 0.00 | 0.00 |
| Selling General And Administration | — | 0.16 Cr | 0.10 Cr | 0.01 Cr | 0.01 Cr |
| Selling And Marketing Expense | — | 0.01 Cr | 0.04 Cr | 0.00 | — |
| General And Administrative Expense | — | 0.15 Cr | 0.06 Cr | 0.01 Cr | 0.01 Cr |
| Rent And Landing Fees | — | 0.70 Cr | 0.12 Cr | 0.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Bandaram Pharma Packtech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.